137 related articles for article (PubMed ID: 25832946)
1. Reappearance of the left ventricular pressure gradient in a patient with hypertrophic obstructive cardiomyopathy.
Ochiumi Y; Ikeda S; Hamada M
Intern Med; 2015; 54(7):805-6. PubMed ID: 25832946
[TBL] [Abstract][Full Text] [Related]
2. Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.
Hamada M; Ikeda S; Ohshima K; Nakamura M; Kubota N; Ogimoto A; Shigematsu Y
J Cardiol; 2016 Mar; 67(3):279-86. PubMed ID: 26116980
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy.
Ogimoto A; Okayama H; Nagai T; Ohtsuka T; Suzuki J; Inoue K; Nishimura K; Saito M; Shigematsu Y; Hamada M; Miki T; Higaki J
J Cardiovasc Pharmacol; 2010 May; 55(5):506-10. PubMed ID: 20179607
[TBL] [Abstract][Full Text] [Related]
4. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.
Hamada M; Shigematsu Y; Ikeda S; Hara Y; Okayama H; Kodama K; Ochi T; Hiwada K
Circulation; 1997 Sep; 96(5):1520-4. PubMed ID: 9315541
[TBL] [Abstract][Full Text] [Related]
5. Cibenzoline improves coronary flow velocity reserve in patients with hypertrophic obstructive cardiomyopathy.
Sekine T; Daimon M; Hasegawa R; Teramoto K; Kawata T; Tanaka N; Takei Y; Takazawa K; Yoshida K; Komuro I
Heart Vessels; 2006 Nov; 21(6):350-5. PubMed ID: 17143709
[TBL] [Abstract][Full Text] [Related]
6. Mitral regurgitation disappearance after cibenzoline treatment in a patient with hypertrophic obstructive cardiomyopathy.
Inada K; Komukai K; Mori C; Nagasawa H; Shibata T; Mochizuki S
Intern Med; 2004 Jan; 43(1):55-8. PubMed ID: 14964580
[TBL] [Abstract][Full Text] [Related]
7. Acute mitral regurgitation in Takotsubo cardiomyopathy.
Bouabdallaoui N; Wang Z; Lecomte M; Ennezat PV; Blanchard D
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):197-9. PubMed ID: 24493864
[TBL] [Abstract][Full Text] [Related]
8. Takotsubo cardiomyopathy with transient left ventricular obstruction successfully treated with cibenzoline succinate: A case report.
Tomofuji K; Ikeda S; Murakami C; Ochiumi Y; Nakamura M; Kadota H; Shimizu H; Oshima K; Hamada M
J Cardiol Cases; 2015 Jun; 11(6):155-157. PubMed ID: 30546553
[TBL] [Abstract][Full Text] [Related]
9. Comparison of acute reduction in left ventricular outflow tract pressure gradient in obstructive hypertrophic cardiomyopathy by disopyramide versus pilsicainide versus cibenzoline.
Kajimoto K; Imai T; Minami Y; Kasanuki H
Am J Cardiol; 2010 Nov; 106(9):1307-12. PubMed ID: 21029829
[TBL] [Abstract][Full Text] [Related]
10. The fuzzy diagnostic boundaries among left ventricular outflow tract obstruction in hypertensive hypertrophy, hypertrophic cardiomyopathy, and Takotsubo syndrome.
Madias JE
Int J Cardiol; 2015 Oct; 197():10. PubMed ID: 26134368
[No Abstract] [Full Text] [Related]
11. [Efficacy of cibenzoline for chest oppression and ventricular arrhythmia during effort and alcohol consumption in a patient with hypertrophic obstructive cardiomyopathy: a case report].
Sasayama T; Horimoto M; Takeda T; Takenaka T; Inoue H; Igarashi K; Akino M; Kikuchi K
J Cardiol; 2000 Jun; 35(6):445-50. PubMed ID: 10884982
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery fistula with associated Takotsubo cardiomyopathy: a case report.
Qureshi R; Kao L; Gupta RP
J Med Case Rep; 2018 Mar; 12(1):86. PubMed ID: 29602306
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous administration of cibenzoline on left ventricular diastolic pressures in patients with hypertrophic cardiomyopathy: its relationship to transmitral Doppler flow profiles.
Hamada M; Aono J; Ikeda S; Watanabe K; Inaba S; Suzuki J; Ohtsuka T; Shigematsu Y
Circ J; 2007 Oct; 71(10):1540-4. PubMed ID: 17895548
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic drug cibenzoline attenuates left ventricular pressure gradient and improves transmitral Doppler flow pattern in patients with hypertrophic obstructive cardiomyopathy caused by midventricular obstruction.
Hamada M; Shigematsu Y; Inaba S; Aono J; Ikeda S; Watanabe K; Ogimoto A; Ohtsuka T; Hara Y; Higaki J
Circ J; 2005 Aug; 69(8):940-5. PubMed ID: 16041163
[TBL] [Abstract][Full Text] [Related]
15. "Incompatible Housemates": Hypertrophic Obstructive Cardiomyopathy and Takotsubo Syndrome.
Sato Y; Matsumoto K; Sakai J; Nakamura T; Tanaka H; Hirata K
Intern Med; 2020 Apr; 59(7):957-962. PubMed ID: 31813917
[TBL] [Abstract][Full Text] [Related]
16. [Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia].
Saito M; Hara Y; Shigematsu Y; Ohtsuka T; Saeki H; Ogimoto A; Yokoyama A; Hamada M
Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):62-4. PubMed ID: 12649850
[TBL] [Abstract][Full Text] [Related]
17. Two cases of apical ballooning syndrome masking apical hypertrophic cardiomyopathy.
Roy RR; Hakim FA; Hurst RT; Simper D; Appleton CP
Tex Heart Inst J; 2014 Apr; 41(2):179-83. PubMed ID: 24808780
[TBL] [Abstract][Full Text] [Related]
18. Transient midventricular ballooning syndrome. an atypical presentation of takotsubo cardiomyopathy.
Rademakers LM; Weijers RW; Wijnbergen IF
Acta Cardiol; 2011 Dec; 66(6):811-3. PubMed ID: 22299396
[TBL] [Abstract][Full Text] [Related]
19. Cibenzoline attenuates coronary systolic reversal flow in a patient with hypertrophic obstructive cardiomyopathy: a case report.
Saihara K; Hamasaki S; Otsuji Y; Yoshitama T; Ishida S; Kataoka T; Okui H; Tei C
J Cardiol; 2006 Oct; 48(4):209-13. PubMed ID: 17066624
[TBL] [Abstract][Full Text] [Related]
20. Takotsubo cardiomyopathy: an Australian single centre experience with medium term follow up.
Samardhi H; Raffel OC; Savage M; Sirisena T; Bett N; Pincus M; Small A; Walters DL
Intern Med J; 2012 Jan; 42(1):35-42. PubMed ID: 21395961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
